Febuxostat Xantis 120 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

febuxostat xantis 120 mg

xantis pharma limited, cyprus - febuxostát - 29 - antirheumatica, antiphlogistica, antiuratica

Febuxostat Xantis 80 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

febuxostat xantis 80 mg

xantis pharma limited, cyprus - febuxostát - 29 - antirheumatica, antiphlogistica, antiuratica

Baqsimi Európska únia - slovenčina - EMA (European Medicines Agency)

baqsimi

eli lilly nederland b.v. - glukagónu - cukrovka - pankreatických hormónov, glycogenolytic hormóny - baqsimi je indikovaný na liečbu ťažkú hypoglykémiu u dospelých, dospievajúcich a detí vo veku 4 rokov a viac s diabetes mellitus.

Phesgo Európska únia - slovenčina - EMA (European Medicines Agency)

phesgo

roche registration gmbh - pertuzumab, trastuzumab - neoplazmy prsníkov - antineoplastické činidlá - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.

Apexxnar Európska únia - slovenčina - EMA (European Medicines Agency)

apexxnar

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumokokové infekcie - vakcíny - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. pozri časti 4. 4 a 5. 1 pre informácie o ochrane proti špecifickým pneumokokovým sérotypom. apexxnar should be used in accordance with official recommendations. .